Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 5.06
-6.99 %
$ 466 M
Market Cap
-4.39
P/E
MYGN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities MYGN - Myriad Genetics, Inc.
153 M
LAST VALUE
73.65%
2 YEAR CAGR
-3.46%
5 YEAR CAGR
10.53%
10 YEAR CAGR